Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study-Reference-Cited by-同舟云学术

Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study

Published:2006-03 Issue:3 Volume:100 Page:537-543
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Long Harry J.,Monk Bradley J.,Huang Helen Q.,Grendys Edward C.,McMeekin D. Scott,Sorosky Joel,Miller David S.,Eaton Lynne A.,Fiorica James V.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference15 articles.

1. Cis-dichlorodiammineplatinum (II) in the treatment of gynecologic malignancies: Phase II trials by the Gynecologic Oncology Group;Thigpen;Cancer Treat. Rep.,1979

2. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study;Omura;J. Clin. Oncol.,1997

3. A randomized phase III study of cisplatin versus cisplatin plus paclitaxel in Stage IVB, recurrent or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study;Moore;J. Clin. Oncol.,2004

4. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix;Fiorica;Gynecol. Oncol.,2002

5. Phase II trial of methotrexate, vinblastine, doxorubicin and cisplatin in advanced/recurrent cancer of the uterine cervix and vagina. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic;Long;Gynecol. Oncol.,1995

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children’s Oncology Group AHOD 1331 study;Journal of Patient-Reported Outcomes;2023-11-10

2. Quality of life in patients with cervical cancer between the Han nationality and ethnic minorities in the Yunnan Province of China;BMC Women's Health;2023-05-03

3. Neurotoxicity of Cisplatin as Monotherapy or Combined Chemotherapy in Cancer Treatment;Clinical Cancer Drugs;2022-03

4. A systematic review of the impact of contemporary treatment modalities for cervical cancer on women’s self-reported health-related quality of life;Supportive Care in Cancer;2020-06-18

5. Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study;International Journal of Gynecologic Cancer;2020-02-28